Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124766953 | 12476695 | 3 | F | 20150625 | 20160706 | 20160617 | 20160715 | EXP | FR-PFIZER INC-2016292564 | PFIZER | 82.00 | YR | F | Y | 0.00000 | 20160715 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124766953 | 12476695 | 1 | PS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, DAILY | U | 12151 | 25 | MG | TABLET | ||||||
| 124766953 | 12476695 | 2 | SS | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, 1X/DAY | U | 0 | 1000 | MG | QD | |||||||
| 124766953 | 12476695 | 3 | I | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, DAILY | U | 0 | 40 | MG | GASTRO-RESISTANT TABLET | ||||||
| 124766953 | 12476695 | 4 | I | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, DAILY | U | 0 | 75 | MG | FILM-COATED TABLET | ||||||
| 124766953 | 12476695 | 5 | SS | DIAMOX /00016901/ | ACETAZOLAMIDE | 1 | Oral | 250 MG, 1X/DAY | U | 0 | 250 | MG | TABLET | QD | |||||
| 124766953 | 12476695 | 6 | C | IKOREL | NICORANDIL | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 124766953 | 12476695 | 7 | C | FUMAFER | FERROUS FUMARATE | 1 | Oral | 0 | FILM-COATED TABLET | ||||||||||
| 124766953 | 12476695 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | ||||||||
| 124766953 | 12476695 | 9 | C | ZAMUDOL | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, 2X/DAY | 0 | 50 | MG | PROLONGED-RELEASE CAPSULE | BID | ||||||
| 124766953 | 12476695 | 10 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 4000 IU, 1X/DAY | 0 | 4000 | IU | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124766953 | 12476695 | 1 | Cardiac failure |
| 124766953 | 12476695 | 2 | Type 2 diabetes mellitus |
| 124766953 | 12476695 | 4 | Ischaemic cardiomyopathy |
| 124766953 | 12476695 | 5 | Cardiac failure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124766953 | 12476695 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124766953 | 12476695 | Drug interaction | |
| 124766953 | 12476695 | Metabolic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124766953 | 12476695 | 1 | 201506 | 0 | ||
| 124766953 | 12476695 | 5 | 201506 | 0 |